WHAT WE DO
Neurocognitive Assessment
Assess various domains of cognition, such as memory, attention, processing speed,
language skills and executive function
language skills and executive function
Neuroimaging
Complete MRI brain scan (for eligible participants) evaluating the
structure of the brain and for the presence of
silent strokes.
structure of the brain and for the presence of
silent strokes.
Blood-based Evaluation
Fasting glucose, lipids, proteins associated with
Alzheimer’s Disease (i.e. amyloid and tau) and
other novel biomarkers.
Retinal Imaging
Evaluate retinal structure and microvascular changes to explore potential links
to cognitive impairment and neurodegenerative processes.
to cognitive impairment and neurodegenerative processes.
